Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML).
Aquaporins (AQPs) have previously been associated with increased expression in solid tumors. However, its expression in hematologic malignancies including CML has not been described yet. Here, we report the expression of AQP5 in CML cells by RT-PCR and immunohistochemistry. While normal bone marrow...
Guardado en:
Autores principales: | Young Kwang Chae, Sung Koo Kang, Myoung Sook Kim, Janghee Woo, Juna Lee, Steven Chang, Dong-Wook Kim, Myungshin Kim, Seonyang Park, Inho Kim, Bhumsuk Keam, Jiyoung Rhee, Nam Hee Koo, Gyeongsin Park, Soo-Hyun Kim, Se-Eun Jang, Il-Young Kweon, David Sidransky, Chulso Moon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0cf4ab838fd34b01827fcbe74e5db4bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death.
por: Guillaume Robert, et al.
Publicado: (2009) -
Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
por: Sang-Min Oh, et al.
Publicado: (2021) -
Dynamics and potential impact of the immune response to chronic myelogenous leukemia.
por: Peter S Kim, et al.
Publicado: (2008) -
Different Expressions of AQP1 and AQP4 in Hyponatremic Rat Brain
por: Lim,Jun Hyeuck, et al.
Publicado: (2021) -
Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
por: So Yeon Oh, et al.
Publicado: (2021)